1 Introduction to Research & Analysis Reports
    1.1 CRISPR/Cas9 Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global CRISPR/Cas9 Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global CRISPR/Cas9 Overall Market Size
    2.1 Global CRISPR/Cas9 Market Size: 2021 VS 2027
    2.2 Global CRISPR/Cas9 Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top CRISPR/Cas9 Players in Global Market
    3.2 Top Global CRISPR/Cas9 Companies Ranked by Revenue
    3.3 Global CRISPR/Cas9 Revenue by Companies
    3.4 Top 3 and Top 5 CRISPR/Cas9 Companies in Global Market, by Revenue in 2020
    3.5 Global Companies CRISPR/Cas9 Product Type
    3.6 Tier 1, Tier 2 and Tier 3 CRISPR/Cas9 Players in Global Market
        3.6.1 List of Global Tier 1 CRISPR/Cas9 Companies
        3.6.2 List of Global Tier 2 and Tier 3 CRISPR/Cas9 Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global CRISPR/Cas9 Market Size Markets, 2021 & 2027
        4.1.2 Genome Editing
        4.1.3 Genetic Engineering
        4.1.4 gRNA Database/Gene Librar
        4.1.5 CRISPR Plasmid
        4.1.6 Human Stem Cells
        4.1.7 Genetically Modified Organisms/Crops
        4.1.8 Cell Line Engineering
    4.2 By Type - Global CRISPR/Cas9 Revenue & Forecasts
        4.2.1 By Type - Global CRISPR/Cas9 Revenue, 2016-2021
        4.2.2 By Type - Global CRISPR/Cas9 Revenue, 2022-2027
        4.2.3 By Type - Global CRISPR/Cas9 Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global CRISPR/Cas9 Market Size, 2021 & 2027
        5.1.2 Biotechnology Companies
        5.1.3 Pharmaceutical Companies
        5.1.4 Academic Institutes
        5.1.5 Research and Development Institutes
    5.2 By Application - Global CRISPR/Cas9 Revenue & Forecasts
        5.2.1 By Application - Global CRISPR/Cas9 Revenue, 2016-2021
        5.2.2 By Application - Global CRISPR/Cas9 Revenue, 2022-2027
        5.2.3 By Application - Global CRISPR/Cas9 Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global CRISPR/Cas9 Market Size, 2021 & 2027
    6.2 By Region - Global CRISPR/Cas9 Revenue & Forecasts
        6.2.1 By Region - Global CRISPR/Cas9 Revenue, 2016-2021
        6.2.2 By Region - Global CRISPR/Cas9 Revenue, 2022-2027
        6.2.3 By Region - Global CRISPR/Cas9 Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America CRISPR/Cas9 Revenue, 2016-2027
        6.3.2 US CRISPR/Cas9 Market Size, 2016-2027
        6.3.3 Canada CRISPR/Cas9 Market Size, 2016-2027
        6.3.4 Mexico CRISPR/Cas9 Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe CRISPR/Cas9 Revenue, 2016-2027
        6.4.2 Germany CRISPR/Cas9 Market Size, 2016-2027
        6.4.3 France CRISPR/Cas9 Market Size, 2016-2027
        6.4.4 U.K. CRISPR/Cas9 Market Size, 2016-2027
        6.4.5 Italy CRISPR/Cas9 Market Size, 2016-2027
        6.4.6 Russia CRISPR/Cas9 Market Size, 2016-2027
        6.4.7 Nordic Countries CRISPR/Cas9 Market Size, 2016-2027
        6.4.8 Benelux CRISPR/Cas9 Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia CRISPR/Cas9 Revenue, 2016-2027
        6.5.2 China CRISPR/Cas9 Market Size, 2016-2027
        6.5.3 Japan CRISPR/Cas9 Market Size, 2016-2027
        6.5.4 South Korea CRISPR/Cas9 Market Size, 2016-2027
        6.5.5 Southeast Asia CRISPR/Cas9 Market Size, 2016-2027
        6.5.6 India CRISPR/Cas9 Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America CRISPR/Cas9 Revenue, 2016-2027
        6.6.2 Brazil CRISPR/Cas9 Market Size, 2016-2027
        6.6.3 Argentina CRISPR/Cas9 Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa CRISPR/Cas9 Revenue, 2016-2027
        6.7.2 Turkey CRISPR/Cas9 Market Size, 2016-2027
        6.7.3 Israel CRISPR/Cas9 Market Size, 2016-2027
        6.7.4 Saudi Arabia CRISPR/Cas9 Market Size, 2016-2027
        6.7.5 UAE CRISPR/Cas9 Market Size, 2016-2027
7 Players Profiles
    7.1 Caribou Biosciences
        7.1.1 Caribou Biosciences Corporate Summary
        7.1.2 Caribou Biosciences Business Overview
        7.1.3 Caribou Biosciences CRISPR/Cas9 Major Product Offerings
        7.1.4 Caribou Biosciences CRISPR/Cas9 Revenue in Global (2016-2021)
        7.1.5 Caribou Biosciences Key News
    7.2 Integrated DNA Technologies(IDT)
        7.2.1 Integrated DNA Technologies(IDT) Corporate Summary
        7.2.2 Integrated DNA Technologies(IDT) Business Overview
        7.2.3 Integrated DNA Technologies(IDT) CRISPR/Cas9 Major Product Offerings
        7.2.4 Integrated DNA Technologies(IDT) CRISPR/Cas9 Revenue in Global (2016-2021)
        7.2.5 Integrated DNA Technologies(IDT) Key News
    7.3 CRISPR Therapeutics
        7.3.1 CRISPR Therapeutics Corporate Summary
        7.3.2 CRISPR Therapeutics Business Overview
        7.3.3 CRISPR Therapeutics CRISPR/Cas9 Major Product Offerings
        7.3.4 CRISPR Therapeutics CRISPR/Cas9 Revenue in Global (2016-2021)
        7.3.5 CRISPR Therapeutics Key News
    7.4 Merck
        7.4.1 Merck Corporate Summary
        7.4.2 Merck Business Overview
        7.4.3 Merck CRISPR/Cas9 Major Product Offerings
        7.4.4 Merck CRISPR/Cas9 Revenue in Global (2016-2021)
        7.4.5 Merck Key News
    7.5 Mirus Bio
        7.5.1 Mirus Bio Corporate Summary
        7.5.2 Mirus Bio Business Overview
        7.5.3 Mirus Bio CRISPR/Cas9 Major Product Offerings
        7.5.4 Mirus Bio CRISPR/Cas9 Revenue in Global (2016-2021)
        7.5.5 Mirus Bio Key News
    7.6 Editas Medicine
        7.6.1 Editas Medicine Corporate Summary
        7.6.2 Editas Medicine Business Overview
        7.6.3 Editas Medicine CRISPR/Cas9 Major Product Offerings
        7.6.4 Editas Medicine CRISPR/Cas9 Revenue in Global (2016-2021)
        7.6.5 Editas Medicine Key News
    7.7 Takara Bio
        7.7.1 Takara Bio Corporate Summary
        7.7.2 Takara Bio Business Overview
        7.7.3 Takara Bio CRISPR/Cas9 Major Product Offerings
        7.4.4 Takara Bio CRISPR/Cas9 Revenue in Global (2016-2021)
        7.7.5 Takara Bio Key News
    7.8 Thermo Fisher Scientific
        7.8.1 Thermo Fisher Scientific Corporate Summary
        7.8.2 Thermo Fisher Scientific Business Overview
        7.8.3 Thermo Fisher Scientific CRISPR/Cas9 Major Product Offerings
        7.8.4 Thermo Fisher Scientific CRISPR/Cas9 Revenue in Global (2016-2021)
        7.8.5 Thermo Fisher Scientific Key News
    7.9 Horizon Discovery Group
        7.9.1 Horizon Discovery Group Corporate Summary
        7.9.2 Horizon Discovery Group Business Overview
        7.9.3 Horizon Discovery Group CRISPR/Cas9 Major Product Offerings
        7.9.4 Horizon Discovery Group CRISPR/Cas9 Revenue in Global (2016-2021)
        7.9.5 Horizon Discovery Group Key News
    7.10 Intellia Therapeutics
        7.10.1 Intellia Therapeutics Corporate Summary
        7.10.2 Intellia Therapeutics Business Overview
        7.10.3 Intellia Therapeutics CRISPR/Cas9 Major Product Offerings
        7.10.4 Intellia Therapeutics CRISPR/Cas9 Revenue in Global (2016-2021)
        7.10.5 Intellia Therapeutics Key News
    7.11 Agilent Technologies
        7.11.1 Agilent Technologies Corporate Summary
        7.11.2 Agilent Technologies Business Overview
        7.11.3 Agilent Technologies CRISPR/Cas9 Major Product Offerings
        7.11.4 Agilent Technologies CRISPR/Cas9 Revenue in Global (2016-2021)
        7.11.5 Agilent Technologies Key News
    7.12 Cellecta
        7.12.1 Cellecta Corporate Summary
        7.12.2 Cellecta Business Overview
        7.12.3 Cellecta CRISPR/Cas9 Major Product Offerings
        7.12.4 Cellecta CRISPR/Cas9 Revenue in Global (2016-2021)
        7.12.5 Cellecta Key News
    7.13 GenScript
        7.13.1 GenScript Corporate Summary
        7.13.2 GenScript Business Overview
        7.13.3 GenScript CRISPR/Cas9 Major Product Offerings
        7.13.4 GenScript CRISPR/Cas9 Revenue in Global (2016-2021)
        7.13.5 GenScript Key News
    7.14 GeneCopoeia
        7.14.1 GeneCopoeia Corporate Summary
        7.14.2 GeneCopoeia Business Overview
        7.14.3 GeneCopoeia CRISPR/Cas9 Major Product Offerings
        7.14.4 GeneCopoeia CRISPR/Cas9 Revenue in Global (2016-2021)
        7.14.5 GeneCopoeia Key News
    7.15 Synthego
        7.15.1 Synthego Corporate Summary
        7.15.2 Synthego Business Overview
        7.15.3 Synthego CRISPR/Cas9 Major Product Offerings
        7.15.4 Synthego CRISPR/Cas9 Revenue in Global (2016-2021)
        7.15.5 Synthego Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer